Taiho Kogyo Co. Ltd. (6470.TO) Japan Year Ended March 31 GROUP 2025 2024 Revenue Y112.79 bln Y112.04 bln Operating Profit Y610.00 mln Y2.49 bln Pretax Profit Y910.00 mln Y3.24 bln Net Profit (Y4 ...

PRINCETON, N.J., April 23, 2025 /PRNewswire/ -- Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced today that ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

"ASCO provides an invaluable opportunity to bring together the leading minds in oncology and discuss emerging new therapies and our understanding of real-world outcomes of existing therapies," said ...

He became known as one of the "Big Four," along with Shofukutei Shokaku VI, Katsura Bunshi V and Katsura Harudanji III. Even among this group, Beicho was particularly scholarly. He revived long ...

ALBANY (TNS) — Headlines across the internet would have you believe dire wolves — a species that went extinct 13,000 years ago, not to be confused wit ...